SEC 13F Intelligence

Managers / Q3 2019 · view latest →

Healthcare Value Capital, LLC

CIK 0001458461 · 50 TICE BLVD, SUITE 140, WOODCLIFF LAKE, NJ, 07677 · 212-488-5411

Reported Value
$55M
Q3 2019
Positions
22
Filings on Record
11
2019–present window
Filed
Nov 14, 2019
original filing

Summary

Healthcare Value Capital, LLC reported $55M in U.S.-listed holdings across 22 positions for Q3 2019.

Its largest position, GILD, represents 8.0% of the portfolio.

Compared with Q2 2019, the fund opened 6 new positions and exited 5.

Portfolio Metrics

Turnover
+38.4%
vs prior filed quarter
Top-10 Concentration
+49.5%
share of reported value
Largest Position
+8.0%
Gilead Sciences
New / Exited
6 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $26MQ1 ’19Q2 ’19: $53MQ3 ’19: $55MQ3 ’19Q4 ’19: $34MQ1 ’20: $59MQ1 ’20Q2 ’20: $39MQ3 ’20: $30MQ3 ’20Q4 ’20: $30MQ1 ’21: $45MQ1 ’21Q2 ’21: $50MQ3 ’21: $51MQ3 ’21filingsflow.com

Portfolio Composition

By security type
Common Stock: 55.6%ETP: 33.9%Other: 10.6%
  • Common Stock · 55.6% · $31M
  • ETP · 33.9% · $19M
  • Other · 10.6% · $6M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
WBAWALGREENS BOOTS ALLIANCE INCNEW+50.0K50.0K+$3M$3M
CAHCARDINAL HEALTH INCNEW+35.0K35.0K+$2M$2M
CORAMERISOURCEBERGEN CORPNEW+20.0K20.0K+$2M$2M
MCKMCKESSON CORPNEW+10.0K10.0K+$1M$1M
CLOVIS ONCOLOGY INCNEW+250.0K250.0K+$983,000$983,000
FOAMIX PHARMACEUTICALS LTDNEW+300.0K300.0K+$912,000$912,000
PROSHARES TR IIADDED+175.0K200.0K+$3M$4M
SPYSPDR S&P 500 ETF TRADDED+30.0K50.0K+$9M$15M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2019

16 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1GILDGILEAD SCIENCES INChistory →COM8.01%$4M70.0K
2GLAXOSMITHKLINE PLCSPONSORED ADR7.71%$4M100.0K
3ABBVABBVIE INChistory →COM6.84%$4M50.0K
4CVSCVS HEALTH CORPhistory →COM5.70%$3M50.0K
5WBAWALGREENS BOOTS ALLIANCE INChistory →COM5.00%$3M50.0K
6TYME TECHNOLOGIES INCCOM4.67%$3M2.17M
7VKTXVIKING THERAPEUTICS INChistory →COM3.11%$2M250.0K
8CAHCARDINAL HEALTH INChistory →COM2.98%$2M35.0K
9CORAMERISOURCEBERGEN CORPhistory →COM2.97%$2M20.0K
10MCKMCKESSON CORPhistory →COM2.47%$1M10.0K
11ADAMAS PHARMACEUTICALS INCCOM1.85%$1M200.0K
12NOVELION THERAPEUTICS INCCOM NEW1.83%$1M1.40M
13CLOVIS ONCOLOGY INCCOM1.78%$983,000250.0K
14FOAMIX PHARMACEUTICALS LTDSHS1.37%$760,000250.0K
15GREENLANE HLDGS INCCL A1.22%$678,000200.0K
16ANTARES PHARMA INCCOM1.21%$669,000200.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2021$51M25Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$50M23Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$45M22May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$30M17Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$30M18Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$39M19Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$59M26May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$34M16Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$55M22Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$53M19Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$26M10May 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.